Get Adobe Flash player
Start About us Company

alexia anapliotis

"We are a family-owned medical technology company located in Berlin, Germany. Focus of our innovative Research and Development activities is developing and producing individual solutions for implants for hip revision, foot surgery, treatment of major bone defects, oncology, periprothetic fractures and trauma implants."

Alexia Anapliotis, CEO

History and Milestones of the Company


merete® launches the PediatrOS™ line at the American Academy of Orthopaedic Surgeons conference

Advertising campaigns, learning labs and on-site demonstrations heighten awareness of merete's reputation and FDA-approved products


merete® debuts an office in the prestigious business district of Oakbrook Terrace, 20 miles from downtown Chicago

merete® Ludloff Plate receives FDA approval

The merete® PediatrOS™ line of pediatric surgical staples receives FDA approval


merete® ScarFix™ plate receives FDA-approval

Introduction of the merete® BioBall® AdapterSelector

Design of MetaFix® OpenWedge plate and MetaFix® MTP Fusion System updated

Foot specimen workshop 2014 is held

Clinical Orthopaedics and Related Research® publishes a promising report on the use of merete® implants in oncology patients

merete®SCARFix Foot Plate receives FDA approval


merete® celebrates the 10th anniversary of  MetaFix®

merete® intends to expand its company location in Luckenwalde (Brandenburg - Germany)

merete receives CE-approval in Europe for EPICAL™ implant surface treatment on its cementless titanium endoprostheses

Introduction of the merete® CS Screws in Germany and USA

Introduction of the merete® CS Screws in Germany and USA

Foot specimen workshop 2013 is held


Alexia Anapliotis is appointed to Co-Managing Director of Merete Medical GmbH.

Merete® Academy is initiated

Preparation workshop series starts


Development and patent application of V-Polyplate locking osteosynthesis plate system.

Development and patent application of MetaFix® Plantar BG10 plate for hallux valgus correction.


FDA approval of OsteoBridge IKA (Intramedullary Knee Arthrodesis) system.

Approval of MEROTAN EPICAL™ hip endoprosthesis.


Extension of OsteoBridge™ system with Knee Arthrodesis implants.


Foundation of affiliate in Poland: Merete Polska in Wroclow.

Building and opening of the state-of-the-art production site in Luckenwalde, Brandenburg. (see photo below)


Foundation of Merete Medical, Inc. in New York State (USA) for the direct selling of foot implants and OsteoBridge™ implants to hospitals and surgeons in the US.

Since then more than 23 FDA registrations have been approved.


Cooperation with BAM Bundesanstalt für Materialforschung und -prüfung (Federal Institute for Materials Research and Testing Berlin) for the development of the EPICAL bioactive titan-surface-process. Grant of world patent.


Dr. Ing. Curt Kranz, the well-known Bioengineer, is appointed to Technical Director. Dr. Kranz reorganizes the R&D department of the company and implements modern production- and quality systems.

Patent for the OsteoBridge® system and development of diaphyseal implants for bone defects and tumor resections.


Begin of development and production of locking implants for foot surgery. The innovative MetaFix™ Hallux Valgus system is registered and marketed internationally.


BioBall®, the innovative hip endoprosthesis modular head system is developed.


Daughter of founder, Alexia Anapliotis, starts in the family company as Head of Sales & Marketing department.


The company is founded by Emmanuel Anapliotis who belongs to the pioneers of the modern orthopedic implant industry in Germany.

The DuoKopf Bipolar Hip Stems, the spheric screw-in cup Mecring, die MecroSet Resection Prostheses and especially the Mecron cannulated screws go back to his company Mecron in the 70's and 80's.



Company sites in Berlin and Luckenwalde

Advertising campaigns, learning labs and on-site demonstrations heighten awareness of merete's reputation and FDA-approved products